This educational activity is designed to provide our faculty with alternative sources of information and experience on controversial areas in diagnostic pathology that cannot be gleaned from reading the literature or standard textbooks in pathology. There are many areas in pathology where a uniformly acceptable standard has not yet been established. Direct interaction with an expert can provide the pathologist with additional insight into more effective ways to handle the issue.
At the conclusion of this activity, learners will be able to:
Explain the most important change in USPSTF recommendations in August 2018
Discuss the most significant end point of research on cervical cancer screening according to the opponents of primary HPV testing
Describe one confounding variable cotesting that might obscure data outcome.
Tina Pejchal, MD, PhD
Surgical Pathology Fellow
Tufts Medical Center
All persons in control of content have NO relevant financial relationships to disclose except the following:
- 1.00 AMA PRA Category 1 Credit(s)™AMA PRA Category 1 Credit(s)™
- 1.00 Hours of ParticipationHours of Participation credit.